Richmond Sy

2.5k total citations · 1 hit paper
17 papers, 1.7k citations indexed

About

Richmond Sy is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Richmond Sy has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Epidemiology and 7 papers in Genetics. Recurrent topics in Richmond Sy's work include Microscopic Colitis (8 papers), Inflammatory Bowel Disease (7 papers) and Celiac Disease Research and Management (4 papers). Richmond Sy is often cited by papers focused on Microscopic Colitis (8 papers), Inflammatory Bowel Disease (7 papers) and Celiac Disease Research and Management (4 papers). Richmond Sy collaborates with scholars based in Canada, United States and Belgium. Richmond Sy's co-authors include David Moher, Vasil Mamaladze, Margaret Sampson, Catherine Dubé, Fatemeh Yazdi, Li Zhang, Irene Pan, Alaa Rostom, Ann Cranney and Navaaz Saloojee and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Richmond Sy

16 papers receiving 1.6k citations

Hit Papers

Effects of Vedolizumab Induction Therapy for Patients Wit... 2014 2026 2018 2022 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
    2014 531 citations Bruce E. Sands, Brian G. Feagan et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richmond Sy Canada 8 1.1k 889 786 702 271 17 1.7k
Rodolfo Rocca Italy 16 1.3k 1.2× 238 0.3× 1.6k 2.1× 963 1.4× 297 1.1× 53 2.1k
Pavol Papay Austria 15 576 0.5× 146 0.2× 632 0.8× 323 0.5× 311 1.1× 37 1.2k
Yinghua Lang United States 9 974 0.9× 125 0.1× 1.2k 1.6× 431 0.6× 303 1.1× 15 1.4k
Benjamin Pariente France 23 1.1k 1.0× 107 0.1× 1.4k 1.8× 665 0.9× 420 1.5× 88 1.8k
Isolde Aerden Belgium 12 1.1k 1.0× 146 0.2× 1.5k 1.9× 821 1.2× 197 0.7× 21 1.8k
Sara Onali Italy 26 709 0.6× 116 0.1× 1.1k 1.3× 514 0.7× 269 1.0× 68 1.5k
Yulia Ron Israel 14 600 0.5× 136 0.2× 793 1.0× 273 0.4× 411 1.5× 47 1.1k
Colleen McElree United States 10 518 0.5× 177 0.2× 1.1k 1.4× 491 0.7× 545 2.0× 11 1.5k
C. Petruzziello Italy 23 570 0.5× 222 0.2× 787 1.0× 536 0.8× 96 0.4× 53 1.1k
Yoav Mazor Israel 17 521 0.5× 144 0.2× 610 0.8× 259 0.4× 300 1.1× 48 1.0k

Countries citing papers authored by Richmond Sy

Since Specialization
Citations

This map shows the geographic impact of Richmond Sy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richmond Sy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richmond Sy more than expected).

Fields of papers citing papers by Richmond Sy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richmond Sy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richmond Sy. The network helps show where Richmond Sy may publish in the future.

Co-authorship network of co-authors of Richmond Sy

This figure shows the co-authorship network connecting the top 25 collaborators of Richmond Sy. A scholar is included among the top collaborators of Richmond Sy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richmond Sy. Richmond Sy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kelly, Erin E., Jeffrey D. McCurdy, Richmond Sy, et al.. (2025). A multivariable prediction model to stratify risk of 90-day rehospitalization among adults with ulcerative colitis. Journal of the Canadian Association of Gastroenterology. 8(2). 76–82.
2.
McCurdy, Jeffrey D., Simon Parlow, Sanjay K. Murthy, et al.. (2023). Video Capsule Endoscopy can Identify Occult Luminal Crohn’s Disease in Patients with Isolated Perianal Fistulas. Journal of Crohn s and Colitis. 17(10). 1624–1630. 3 indexed citations
3.
McCurdy, Jeffrey D., et al.. (2022). Pancolonic Dye Spray Chromoendoscopy to Detect and Resect Ill-Defined Neoplastic Lesions in Colonic Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 6(1). 37–41. 3 indexed citations
4.
5.
Sy, Richmond, et al.. (2018). A128 DIAGNOSTIC YIELD OF CAPSULE ENDOSCOPY AND INFLAMMATORY BOWEL DISEASE SEROLOGY IN PATIENTS WITH ISOLATED COMPLEX PERIANAL FISTULAS. Journal of the Canadian Association of Gastroenterology. 1(suppl_2). 193–193. 1 indexed citations
6.
Park, Angela, et al.. (2016). Use of Statins to Augment Progenitor Cell Function in Preclinical and Clinical Studies of Regenerative Therapy: a Systematic Review. Stem Cell Reviews and Reports. 12(3). 327–339. 21 indexed citations
7.
Grabowski, Jenny, et al.. (2015). Su1254 Predictors of 30 Day Readmission Rates in Inflammatory Bowel Disease Patients After Hospital Discharge. Gastroenterology. 148(4). S–452. 1 indexed citations
8.
Sands, Bruce E., Brian G. Feagan, Paul Rutgeerts, et al.. (2014). Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed. Gastroenterology. 147(3). 618–627.e3. 531 indexed citations breakdown →
9.
10.
Khanna, Reena, Waqqas Afif, Eric I. Benchimol, et al.. (2013). Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 38(5). 447–459. 87 indexed citations
11.
Sands, Bruce E., Brian G. Feagan, Paul Rutgeerts, et al.. (2012). Vedolizumab Induction Therapy for Patients With Crohn’s Disease and Prior Anti-TNF Antagonist Failure: A Randomized, Placebo-controlled, Double-blind, Multicenter Trial. Inflammatory Bowel Diseases. 18. S24–S25. 3 indexed citations
12.
Booth, Ronald A., Mohammed Ansari, Evelin Loit, et al.. (2011). Assessment of Thiopurine S-Methyltransferase Activity in Patients Prescribed Thiopurines: A Systematic Review. Annals of Internal Medicine. 154(12). 814–823. 84 indexed citations
13.
Booth, Ronald A., Mohammed T Ansari, Andrea C. Tricco, et al.. (2010). Assessment of thiopurine methyltransferase activity in patients prescribed azathioprine or other thiopurine-based drugs.. PubMed. 1–282. 7 indexed citations
14.
Rostom, Alaa, Catherine Dubé, Ann Cranney, et al.. (2005). The diagnostic accuracy of serologic tests for celiac disease: A systematic review. Gastroenterology. 128(4). S38–S46. 394 indexed citations
15.
Cranney, Ann, Alaa Rostom, Richmond Sy, et al.. (2005). Consequences of testing for celiac disease. Gastroenterology. 128(4). S109–S120. 25 indexed citations
16.
Dubé, Catherine, Alaa Rostom, Richmond Sy, et al.. (2005). The prevalence of celiac disease in average-risk and at-risk Western European populations: A systematic review. Gastroenterology. 128(4). S57–S67. 477 indexed citations
17.
Rostom, Alaa, Catherine Dubé, Ann Cranney, et al.. (2004). Celiac Disease: Summary. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rodolfo Rocca Breakdown of academic impact, for papers by Pavol Papay Breakdown of academic impact, for papers by Yinghua Lang Breakdown of academic impact, for papers by Benjamin Pariente Breakdown of academic impact, for papers by Isolde Aerden Breakdown of academic impact, for papers by Sara Onali Breakdown of academic impact, for papers by Yulia Ron Breakdown of academic impact, for papers by Colleen McElree Breakdown of academic impact, for papers by C. Petruzziello Breakdown of academic impact, for papers by Yoav Mazor
Rankless by CCL
2026